|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Taneja P, Maglic D, Kai F, Zhu S, Kendig
RD, Fry EA and Inoue K: Classical and novel prognostic markers for
breast cancer and their clinical significance. Clin Med Insights
Oncol. 4:15–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Winter J, Jung S, Keller S, Gregory RI and
Diederichs S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van Rooij E: The art of microRNA research.
Circ Res. 108:219–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rosa A and Brivanlou AH: MicroRNAs in
early vertebrate development. Cell Cycle. 8:3513–3520. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ren Y, Chen Y, Liang X, Lu Y, Pan W and
Yang M: MiRNA-638 promotes autophagy and malignant phenotypes of
cancer cells via directly suppressing DACT3. Cancer Lett.
390:126–136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhan MN, Yu XT, Tang J, Zhou CX, Wang CL,
Yin QQ, Gong XF, He M, He JR, Chen GQ, et al: MicroRNA-494 inhibits
breast cancer progression by directly targeting PAK1. Cell Death
Dis. 8:e25292017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang C, Li Q, Liu F, Chen X, Nesa EU, Guan
S, Liu B, Han L, Tan B, Wang D, et al: Serum miR-1297: a promising
diagnostic biomarker in esophageal squamous cell carcinoma.
Biomarkers. 21:517–522. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ju HQ, Lu YX, Chen DL, Tian T, Mo HY, Wei
XL, Liao JW, Wang F, Zeng ZL, Pelicano H, et al: Redox regulation
of stem-like cells though the CD44v-xCT axis in colorectal cancer:
Mechanisms and therapeutic implications. Theranostics. 6:1160–1175.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang C, Chi YL, Wang PY, Wang YQ, Zhang
YX, Deng J, Lv CJ and Xie SY: miR-511 and miR-1297 inhibit human
lung adenocarcinoma cell proliferation by targeting oncogene TRIB2.
PLoS One. 7:e460902012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Xu X, Mo S, Tian Y, Wu J, Zhang J
and Zhao J: Involvement of microRNA-1297, a new regulator of HMGA1,
in the regulation of glioma cell growth in vivo and in vitro. Am J
Transl Res. 8:2149–2158. 2016.PubMed/NCBI
|
|
15
|
Wu XJ, Pu XM, Zhao ZF, Zhao YN, Kang XJ,
Wu WD, Zou YM, Wu CY, Qu YY, Zhang DZ, et al: The expression
profiles of microRNAs in Kaposis sarcoma. Tumour Biol. 36:437–446.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Liang H and Jiang X: MiR-1297
promotes apoptosis and inhibits the proliferation and invasion of
hepatocellular carcinoma cells by targeting HMGA2. Int J Mol Med.
36:1345–1352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu F, He Y, Shu R and Wang S:
MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation
and apoptosis by targeting EZH2. Int J Clin Exp Pathol.
8:4972–4980. 2015.PubMed/NCBI
|
|
18
|
Liang X, Li H, Fu D, Chong T, Wang Z and
Li Z: MicroRNA-1297 inhibits prostate cancer cell proliferation and
invasion by targeting the AEG-1/Wnt signaling pathway. Biochem
Biophys Res Commun. 480:208–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen P, Wang BL, Pan BS and Guo W:
MiR-1297 regulates the growth, migration and invasion of colorectal
cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer
Prev. 15:9185–9190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li X, Wang HL, Peng X, Zhou HF and Wang X:
miR-1297 mediates PTEN expression and contributes to cell
progression in LSCC. Biochem Biophys Res Commun. 427:254–260. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang NQ, Luo XJ, Zhang J, Wang GM and Guo
JM: Crosstalk between Meg3 and miR-1297 regulates growth of
testicular germ cell tumor through PTEN/PI3K/AKT pathway. Am J
Transl Res. 8:1091–1099. 2016.PubMed/NCBI
|
|
22
|
Yang NQ, Zhang J, Tang QY, Guo JM and Wang
GM: miRNA-1297 induces cell proliferation by targeting phosphatase
and tensin homolog in testicular germ cell tumor cells. Asian Pac J
Cancer Prev. 15:6243–6246. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Z, Liu Y, Shi C, Zhang Y, Lv R, Zhang
R, Wang Q and Wang Y: Suppression of PTEN/AKT signaling decreases
the expression of TUBB3 and TOP2A with subsequent inhibition of
cell growth and induction of apoptosis in human breast cancer MCF-7
cells via ATP and caspase-3 signaling pathways. Oncol Rep.
37:1011–1019. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li Z, Meng Q, Pan A, Wu X, Cui J, Wang Y
and Li L: MicroRNA-455-3p promotes invasion and migration in triple
negative breast cancer by targeting tumor suppressor EI24.
Oncotarget. 8:19455–19466. 2016.
|
|
25
|
Xue Y, Xu W, Zhao W, Wang W, Zhang D and
Wu P: miR-381 inhibited breast cancer cells proliferation,
epithelial-to-mesenchymal transition and metastasis by targeting
CXCR4. Biomed Pharmacother. 86:426–433. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Atmaca H, Özkan AN and Zora M: Novel
ferrocenyl pyrazoles inhibit breast cancer cell viability via
induction of apoptosis and inhibition of PI3K/Akt and ERK1/2
signaling. Chem Biol Interact. 263:28–35. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hohensee I, Chuang HN, Grottke A, Werner
S, Schulte A, Horn S, Lamszus K, Bartkowiak K, Witzel I, Westphal
M, et al: PTEN mediates the cross talk between breast and glial
cells in brain metastases leading to rapid disease progression.
Oncotarget. 8:6155–6168. 2017.PubMed/NCBI
|
|
28
|
Rangel R, Lee SC, Ban Hon-Kim K,
Guzman-Rojas L, Mann MB, Newberg JY, Kodama T, McNoe LA, Selvanesan
L, Ward JM, et al: Transposon mutagenesis identifies genes that
cooperate with mutant Pten in breast cancer progression. Proc Natl
Acad Sci USA. 113:E7749–E7758. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang LL, Hao S, Zhang S, Guo LJ, Hu CY,
Zhang G, Gao B, Zhao JJ, Jiang Y, Tian WG, et al: PTEN/PI3K/AKT
protein expression is related to clinicopathologic features and
prognosis in breast cancer with axillary lymph node metastases. Hum
Pathol. 61:49–57. 2016. View Article : Google Scholar : PubMed/NCBI
|
